drugset / Trial / NCT03388853
Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD.
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective is to assess efficacy and safety of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet once daily treatment besides standard/usual treatment, as compared with placebo once daily in patients with stable moderate to severe COPD.
Timeline
- Start
- 2018-02-20
- Primary completion
- 2019-12-21
- Completion
- 2019-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxofylline | Small molecule | 400 mg | — |
| Subject | N-acetylcysteine | Small molecule | 1200 mg | — |